Clinical Trial Update: A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)

View source ↗

Summary

Clinical trial update reporting completion of a study of dupilumab treatment in adolescent participants with severe uncontrolled asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Status: COMPLETED